news
Apothékary Raises $16M for Retail and Product Expansion
Herbal tincture brand Apothékary secured $16 million in Series A funding ($10M VC, $6M debt) to fuel its retail expansion and new product development. Co-founder and CEO Shizu Okusa noted that Apothékary is seeing 80% repeat customers and a low customer acquisition cost. This cash influx positions them to scale their herbal remedies, which promise targeted benefits like stress relief and improved sleep.
Herbal tincture brand Apothékary secured $16 million in Series A funding ($10M VC, $6M debt) to fuel its retail expansion and new product development. Co-founder and CEO Shizu Okusa noted that Apothékary is seeing 80% repeat customers and a low customer acquisition cost. This cash influx positions them to scale their herbal remedies, which promise targeted benefits like stress relief and improved sleep.
The architecture take
The funding signals that personalized, plant-based remedies are still a strong bet, especially as consumers look for nuanced ways to manage stress and support their nervous systems without traditional meds.